; and (v) social support, the necessary resources needed, beyond the direct delivery of health care, to ensure effective care; and (B) financing the discovery and development of urgently needed new health technologies such as diagnostics, treatments, and vaccines, particularly for neglected diseases of poverty, and ensuring their availability as global public goods; (2) the objectives described in paragraph (1) will require— (A) increased United States investment in development assistance over the coming years, sufficient to— (i) for the first time, meet the United Nations development assistance target of spending the equivalent of 0.7 percent gross national income on development assistance, which 6 other countries have previously met; and (ii) close over 100 percent of the previously described essential universal health coverage financing gap for low-income countries, and 30 percent of the overall financing gap for low- and lower-middle-income countries, by dedicating $125,000,000,000 per year for global health investment; (B) optimizing global health delivery spending by— (i) introducing a new form of coordinated multilateral fiscal cooperation for global public investment that ensures increased and ongoing global public funding of common goods for health, exhibiting shared governance with global South governments and meaningful participation of civil society, which is also essential for addressing intersectional crises of social inequalities including the climate crisis; (ii) ensuring funding directly supports national health plans, public institutions, local priorities, and donor coordination, practices aligned with what Dr. Paul Farmer called accompaniment ; and (iii) focusing on health service delivery for vulnerable populations, such as people living in poverty, women, and children; and (C) optimizing research and development spending for neglected diseases of poverty by ensuring the knowledge and technology produced by these efforts remains accessible to all as global public goods